US · BJDX
Bluejay Diagnostics, Inc.
- Sector
- Healthcare · Medical - Devices
- Headquarters
- Acton, MA 01720
- Website
- bluejaydx.com
Price · as of 2024-12-31
$1.92
Market cap 929.76K
Valuation summary
Four models, one snapshot. Upside is target ÷ current − 1.
| Valuation method | Value, $ | Upside, % |
|---|---|---|
| Artificial Intelligence(AI) | — | — |
| Intrinsic Value(DCF) | — | — |
| Graham-Dodd Method(GD) | — | — |
| Graham Formula(GF) | — | — |
Valuation history
Annual price (USD per share) overlaid with each model's fair value. Y-axis is log scale.
| Year | Price | AI | DCF | Graham-Dodd | Graham Formula |
|---|---|---|---|---|---|
| 2010 | |||||
| 2011 | |||||
| 2012 | |||||
| 2013 | |||||
| 2014 | |||||
| 2015 | |||||
| 2016 | |||||
| 2017 | |||||
| 2018 | |||||
| 2019 | |||||
| 2020 | |||||
| 2021 | $30,400.00 | ||||
| 2022 | $19,040.00 | ||||
| 2023 | $1,438.40 | $581.13 | |||
| 2024 | $16.76 |
AI valuation
Our deep-learning model estimates Bluejay Diagnostics, Inc.'s (BJDX) per-share fair value from quarterly fundamentals, sector trend, and historical valuation patterns.
- AI fair value
- —
- Current price
- $1.92
- AI upside
- —
Methodology and confidence bands appear in the dedicated valuation theory section. The AI score is an estimate, not a recommendation.
Intrinsic value (DCF)
Open DCF calculatorThree textbook valuation models, recomputed daily from the latest financial statements. The DCF uses our Chepakovich model. Graham-Dodd and Graham Formula are conservative reference points.
DCF
—
— upside
Graham-Dodd
—
— upside
Graham Formula
—
— upside
Peer comparison
Same-industry comparables, ranked by market cap.
| Basic Info | Model Valuation | Core Valuation | Profitability | Leverage & Liquidity | Growth | Cash Flow | Dividends | Enterprise Value | Risk | ||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ticker | Company Name | Price | Market Cap | AI Upside | DCF Upside | GD Upside | GF Upside | P/E | P/B | P/S | EV/EBITDA | PEG | P/TBV | Gross Margin | Operating Margin | Net Margin | ROE | ROIC | ROA | Debt/Equity | Interest Coverage | Current Ratio | Quick Ratio | Net Debt/EBITDA | EPS Growth | Sales Growth | FCF Growth | FCF Yield | Op Cash Flow Ratio | Cash ROIC | Dividend Yield | Dividend Payout | Shareholder Yield | EV/EBIT | EV/FCF | EV/Sales | Altman Z-Score |
| BJDX | Bluejay Diagnostics, Inc. | $1.92 | 929.76K | — | — | — | — | -0.10 | 0.13 | — | 0.49 | -0.17 | 0.13 | 0.00% | — | — | -178.98% | -533.23% | -133.92% | 0.04 | -8.71 | 6.05 | 5.33 | 0.61 | 5724.00% | — | -989.00% | -1057.58% | -9.65 | -604.40% | 0.00% | 0.00% | 289.45% | 0.46 | 0.41 | — | -9.61 |
| BCTXZ | BriaCell Therapeutics Cor… | $0.17 | 315.72K | — | — | — | — | — | — | — | — | — | — | 0.00% | — | — | -237.76% | -2090.29% | -192.98% | 0.00 | -735.71 | 5.01 | 4.69 | 0.29 | 191519.00% | — | 1459.00% | — | -7.08 | -1560.53% | — | 0.00% | — | — | — | — | — |
| ELAB | PMGC Holdings Inc. | $1.19 | 126.21K | +401,467% | +24,631% | — | — | -0.06 | 0.06 | 0.16 | 1.12 | — | 0.10 | 72.84% | -75.65% | -253.14% | -119.12% | -110.26% | -88.07% | 0.00 | -2.54 | 3.36 | 2.22 | 1.25 | -8600.00% | 4407.00% | 2032.00% | -1366.73% | -3.05 | -324.66% | 0.00% | 0.00% | 215.87% | 1.92 | 0.65 | -1.45 | -1.81 |
| MLEC | Moolec Science S.A. | $13.30 | 9.66M | +7,515% | +24,189,467% | — | — | -0.07 | -0.12 | 0.02 | -3.56 | 0.00 | -0.05 | 34.17% | -3.14% | -33.41% | 376.84% | -11.15% | -93.08% | -3.74 | -0.25 | 0.13 | 0.12 | -3.57 | 897895.00% | 583074.00% | 21733.00% | -393.07% | -0.10 | -32.03% | 0.00% | 0.00% | 12.10% | -23.43 | -8.16 | 0.74 | -0.48 |
| MSPR | MSP Recovery, Inc. | $0.04 | 537.2K | +14,182% | +17,977% | — | — | -0.01 | 0.14 | 0.76 | -1.22 | -0.01 | -0.01 | 47.36% | -6982.79% | -1975.45% | -834.83% | -139.81% | -61.30% | 7.90 | -3.03 | 0.01 | 0.01 | -1.20 | 12779.00% | 13685.00% | -6014.00% | -119.26% | -0.01 | -1.83% | 0.00% | 0.00% | 0.00% | -0.62 | -47.84 | 43.63 | -3.28 |
| TIVC | Tivic Health Systems, Inc… | $0.82 | 889.68K | +3,622% | +81% | — | -43% | -189.04 | 421.70 | 1370.53 | -200.98 | — | 421.70 | 0.26% | -725.77% | -725.00% | -184.96% | -1041.58% | -142.01% | 0.00 | — | 9.70 | 7.61 | 0.38 | -8887.00% | -3367.00% | -3365.00% | -0.54% | -21.05 | -1053.36% | 0.00% | 0.00% | 0.00% | -188.49 | -186.38 | 1367.97 | 2331.04 |
| UPC | Universe Pharmaceuticals … | $2.72 | 1.53M | +5,735,314% | +242,398% | +399,145% | +515,984% | 0.00 | 0.00 | 0.00 | 8.32 | — | 0.00 | 35.28% | -16.33% | -20.56% | -7.23% | -10.45% | -5.35% | 0.16 | -12.57 | 4.07 | 3.55 | 8.33 | -2649.00% | -2244.00% | -4529.00% | -37140.54% | -0.38 | -19.36% | 0.00% | 0.00% | 19477.17% | 8.34 | 4.50 | -1.36 | 0.54 |
| WGS | GeneDx Holdings Corp. | $79.71 | 2.3B | +102% | -61% | -91% | — | -94.92 | 6.47 | 4.67 | 298.22 | — | 15.81 | 69.74% | -2.76% | -4.92% | -7.60% | -4.61% | -4.25% | 0.49 | -4.65 | 2.46 | 2.26 | 7.09 | -6237.00% | 3997.00% | -14196.00% | 0.71% | 0.31 | 5.60% | 0.00% | 0.00% | 0.00% | -167.43 | 138.55 | 4.62 | 2.21 |
About Bluejay Diagnostics, Inc.
Bluejay Diagnostics, Inc. operates as a medical diagnostics company. The company offers the Symphony platform, a technology platform comprising the Symphony analyzer that orchestrates whole blood processing, biomarker isolation, and immunoassay preparation using non-contact centrifugal force; and the Symphony Cartridge, which includes reagents and components. It also provides the ALLEREYE diagnostic test, a point-of-care device for the diagnosis of allergic conjunctivitis. In addition, the company develops Symphony IL-6 tests for the monitoring of disease progression in critical care settings. Further, it is developing additional tests for Symphony, such as tests for myocardial infraction and congestive heart failure. Bluejay Diagnostics, Inc. was incorporated in 2015 and is headquartered in Acton, Massachusetts.
- CEO
- Indranil Dey
- Employees
- 7
- Beta
- 0.67
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Upside computed as (— ÷ $1.92) − 1 = — (DCF, example).